Charter Bioanalytics is an independent third-party laboratory founded to answer one question that customers in the research-peptide market keep asking: is what I have what the label says it is?
The research-peptide industry has a credibility problem. Customers receive vials with labels claiming purity, mass, and endotoxin specifications they have no way to verify. The labs that do exist often return data that's hard to read — a number on a page, no clear verdict, no per-criterion grading, no traceability beyond the file itself.
We started Charter to fix the report. Every Charter report is a single page that any researcher, supplier, or auditor can pick up and read in 30 seconds. The verdict is visible immediately. The criteria that contributed to that verdict are graded individually. The methods and reference standards are stated. The result is reproducible. The report is verifiable.
Three commitments that show up in every Charter report:
Charter is led by a small team with backgrounds in analytical chemistry, regulatory compliance, and pharmaceutical QC.
Lead Analyst · HPLC
Method development and validation for RP-HPLC peptide assays. Ten years at a contract pharmaceutical lab prior to Charter.
Technical Reviewer · QC
Analytical chemistry doctorate (2017). Reviews every report before sign-off. Specializes in endotoxin (LAL) method validation per USP <85>.
Lab Team
A team of laboratory technicians, sample handlers, and QA reviewers — every shift double-blind reviewed.
Charter Bioanalytics, LLC is registered in New Mexico. Our facility is located in Santa Fe with sample receipt and reporting handled within the same building. We do not subcontract analytical work to other labs.